References
- Fischer V., Haar J., Greiner L., Lloyd R., Mason R. Possible role of free radical formation in clozapine (Clozaril)-induced agranulocytosis. Molecular Pharmacology 1991; 40: 846–853
- Fitton A., Hell R. Clozapine: a review of its pharmacological properties and therapeutic use in the treatment of schizophrenia. Drugs 1990; 40: 722–747
- Gauch R., Michaelis W. The metabolism of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine (clozapine) in mice, dogs and human subjects. Farmaco 1971; 26: 667–681
- Gerson S., Meltzer H. Mechanisms of clozapine induced agranulocytosis. Drug Safety 1992; 7(suppl. 1)17–25
- Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment resistant schizophrenic. A double blind comparison with chlorpromazine/benztropine. Archives of General Psychiatry 1988; 45: 789–796
- Lambert R. Surgery of the Digestive System of the Rat, B. Julien. Charles C. Thomas, Springfield, Illinois 1965
- Lieberman J., Johns C., Kane J., Rai K., Pisciotta A., Saltz B., Howard A. Clozapine induced agranulocytosis: non-cross-reactivity with other psychotropic drugs. Journal of Clinical Psychiatry 1988; 49: 271–277
- Mason R., Fischer V. Possible role of free radical formation in drug-induced agranulocytosis. Drug Safety 1992; 7(suppl. 1)45–50
- Meltzer H., Bastani B., Young Kwon K., Ramirez L., Burnet S., Sharpe J. A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report. Psychopharmacology 1989; 99: S68–72
- Mulder G., Scholtens E., Meijer D. Collection of metabolites from bile and urine from the rat. Methods in Enzymology 1981; 77: 21–30
- Utrecht J. Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis. Drug Safety 1992; 7(suppl. 1)51–56
- Von Stock B., Spiteller G., Heipertz R. Austausch aromatisch gebundenen Halogens gegen OH- und SCH3 bei der Metabolisierung des Clozapins im menschlichen Korper. Arzneimittel-Forschung/Drug Research 1977; 27: 982–990